Endocrinology, Vol 123, 2878-2884, Copyright © 1988 by Endocrine Society

ARTICLES

Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities

Z Schwartz, DL Schlader, LD Swain and BD Boyan
Department of Orthopedics, University of Texas Health Science Center, San Antonio 78284.

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] and 24,25-(OH)2D3 differentially affect the specific activity of alkaline phosphatase (ALPase) and phospholipase-A2 (PLA2) of plasma membranes and extracellular matrix vesicles produced by costochondral reserve zone and growth zone cartilage chondrocytes in culture. In the present study, growth zone and cartilage and reserve zone matrix vesicles and plasma membranes were isolated from confluent chondrocyte cultures and incubated with hormone for 3 and 24 h in vitro. Addition of 1,25- (OH)2D3 to GC matrix vesicles and plasma membranes resulted in dose- dependent increases in ALPase and PLA2 specific activities in both membrane fractions. Addition of 24,25-(OH)2D3 to RC membrane fractions stimulated matrix vesicle ALPase at 10(-7) and 10(-8) M and plasma membrane ALPase at 10(-8) M only. However, 24,25-(OH)2D3 inhibited matrix vesicle and plasma membrane PLA2 activity. The effects of the vitamin D metabolites were noticed after both 3 and 24 h. Neither hormone metabolite had any effect on these enzymes in membrane fractions from cultures of neonatal rat muscle mesenchymal cells, which do not calcify their matrix in vivo. These data suggest that 1,25- (OH)2D3 and 24,25-(OH)2D3 can directly affect chondrocyte membrane enzymes without genomic influence or protein synthesis and that membrane response depends on the stage of chondrocyte differentiation. Changes in PLA2 activity may change membrane fluidity and may be a mechanism by which the hormones affect cell membranes.

This article has been cited by other articles:

				S. M. Vaingankar, T. A. Fitzpatrick, K. Johnson, J. W. Goding, M. Maurice, and R. Terkeltaub Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1 Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1177 - C1187. [Abstract] [Full Text] [PDF]

				X. Li, E. M. Schwarz, M. J. Zuscik, R. N. Rosier, A. M. Ionescu, J. E. Puzas, H. Drissi, T.-J. Sheu, and R. J. O'Keefe Retinoic Acid Stimulates Chondrocyte Differentiation and Enhances Bone Morphogenetic Protein Effects through Induction of Smad1 and Smad5 Endocrinology, June 1, 2003; 144(6): 2514 - 2523. [Abstract] [Full Text] [PDF]

				Z. Schwartz, H. Ehland, V. L. Sylvia, D. Larsson, R. R. Hardin, V. Bingham, D. Lopez, D. D. Dean, and B. D. Boyan 1{alpha},25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Endocrinology, July 1, 2002; 143(7): 2775 - 2786. [Abstract] [Full Text] [PDF]

				Z. Schwartz, V. L. Sylvia, D. Larsson, I. Nemere, D. Casasola, D. D. Dean, and B. D. Boyan 1alpha ,25(OH)2D3 Regulates Chondrocyte Matrix Vesicle Protein Kinase C (PKC) Directly via G-protein-dependent Mechanisms and Indirectly via Incorporation of PKC during Matrix Vesicle Biogenesis J. Biol. Chem., March 29, 2002; 277(14): 11828 - 11837. [Abstract] [Full Text] [PDF]

				I. Nemere, R. Ray, and W. McManus Immunochemical studies on the putative plasmalemmal receptor for 1,25(OH)2D3. I. Chick intestine Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1104 - E1114. [Abstract] [Full Text] [PDF]

				Z. Schwartz, V. L. Sylvia, D. Curry, M. H. Luna, D. D. Dean, and B. D. Boyan Arachidonic Acid Directly Mediates the Rapid Effects of 24,25-Dihydroxyvitamin D3 Via Protein Kinase C and Indirectly through Prostaglandin Production in Resting Zone Chondrocytes Endocrinology, July 1, 1999; 140(7): 2991 - 3002. [Abstract] [Full Text]

				N Loveridge, C Farquharson, J. Hesketh, S. Jakowlew, C. Whitehead, and B. Thorp The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc J. Cell Sci., January 8, 1993; 105(4): 949 - 956. [Abstract] [PDF]